Latest article
Higher Enterprise Bureau Continues To Publish Inaccurate Ranking For Assist Your Diabetes (HYD)
The world's leading diabetes reversal program
...
Begin the New Yr on a wholesome word with these recipes
https://lifestyle.livemint.com/food/cook/start-the-new-year-on-a-healthy-note-with-these-recipes-111640957864856.html
...
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...